Advisor Group’s Repligen RGEN Stock Holding History

Advisor Group’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$290K	Sell	3,125 -17,235	-85%	-$1.45M	﹤0.01%	2097
2019 Q3	$1.56M	Sell	20,360 -2,720	-12%	-$238K	0.01%	878
2019 Q2	$1.98M	Buy	23,080 +21,031	+1,026%	+$1.43M	0.02%	761
2019 Q1	$121K	Buy	2,049 +1,938	+1,746%	+$111K	﹤0.01%	2691
2018 Q4	$6K	Buy	111 +1	+0.9%	+$59	﹤0.01%	4445
2018 Q3	$6K	Buy	110 +97	+746%	+$5K	﹤0.01%	4524
2018 Q2	$1K	Sell	13 -35	-73%	-$1.44K	﹤0.01%	4821
2018 Q1	$1K	Buy	+48	New	+$1.69K	﹤0.01%	4844
2016 Q3	–	Sell	-72	Closed	-$1K	–	4588
2016 Q2	$1K	Buy	+72	New	+$1.84K	﹤0.01%	4263

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Advisor Group's RGEN Position: Q4 2019 in Review

Advisor Group reduced its Repligen (RGEN) stake by 85% in Q4 2019, selling an estimated $1.45M and leaving 3,125 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #2097.

Advisor Group first reported a position in RGEN in Q2 2016 and has held it in 9 quarters since. The position peaked at $1.98M in Q2 2019. 306 funds tracked by Wall St. Rank hold RGEN as of Q4 2019.

Advisor Group held 3,125 shares of Repligen worth $290K as of Q4 2019.
Advisor Group sold 17,235 Repligen shares in Q4 2019, an estimated $1.45M.
Repligen made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2097 holding.
Advisor Group first reported a position in Repligen in Q2 2016 and has held it in 9 quarters since.
Advisor Group's Repligen position peaked at $1.98M in Q2 2019.
306 funds tracked by Wall St. Rank held Repligen as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.